Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ERAS Erasca > Detailed Quotes

ERAS Erasca

Watchlist
4.000
+0.030+0.76%
Close  01/31 16:00 ET
4.0000.0000.00%
Post Mkt Price 01/31 16:26 ET
High
4.110
Open
3.970
Turnover
5.26M
Low
3.930
Pre Close
3.970
Volume
1.31M
Market Cap
600.22M
P/E(TTM)
Loss
52wk High
12.800
Shares
150.05M
P/E(Static)
Loss
52wk Low
3.600
Float Cap
327.04M
Bid/Ask %
0.00%
Historical High
24.470
Shs Float
81.76M
Volume Ratio
1.61
Historical Low
3.600
Dividend TTM
--
Div Yield TTM
--
P/B
1.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.61%
Amplitude
4.53%
Avg Price
4.004
Lot Size
1
Float Cap
327.04M
Bid/Ask %
0.00%
Historical High
24.470
Shs Float
81.76M
Volume Ratio
1.61
Historical Low
3.600
Dividend TTM
--
P/B
1.64
Dividend LFY
--
Turnover Ratio
1.61%
Amplitude
4.53%
Avg Price
4.004
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Erasca, Inc. is a clinical stage precision oncology company, It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 2, 2018 and is headquartered in San Diego, CA.
CEO: Dr. Jonathan E. Lim,M.D.
Market: NASDAQ
Listing Date: 07/16/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist